Sevref Tablets (Sevelamer Carbonate Tablets 800mg, 10x1x10)

Sevref Tablets, containing Sevelamer Carbonate 800mg, are widely prescribed for patients with chronic kidney disease (CKD) to control high phosphate levels in the blood. By binding to phosphate from food, Sevref helps reduce complications such as bone problems and cardiovascular disease, improving the quality of life for renal patients.

Description

Sevref Tablets, containing Sevelamer Carbonate 800mg, are widely prescribed for patients with chronic kidney disease (CKD) to control high phosphate levels in the blood. By binding to phosphate from food, Sevref helps reduce complications such as bone problems and cardiovascular disease, improving the quality of life for renal patients.

Key Features:

  • Active Ingredient: Sevelamer Carbonate 800mg

  • Pack Size: 10x1x10 tablets

  • Indicated for hyperphosphatemia in CKD patients

  • Reduces phosphate absorption effectively

  • Trusted by nephrologists across India

Why Choose Biophar Lifesciences?
Biophar Lifesciences has built a strong reputation for delivering innovative and reliable nephrology products. The company provides lucrative pharma franchise business opportunities to entrepreneurs, distributors, and healthcare professionals across India.

Franchise Opportunity Benefits:
✅ Wide product portfolio in nephrology, cardiology, dermatology, and general medicines
✅ Monopoly distribution rights ensuring minimal competition
✅ Attractive profit margins & long-term growth potential
✅ Backed by WHO-GMP & ISO certifications
✅ Dedicated promotional and marketing materials

👉 With the rising demand for renal care medicines like Sevref Tablets, associating with Biophar Lifesciences ensures both business growth and patient care excellence.